Portal de Periódicos da CAPES

Group A streptococcal antigens and superantigens in the pathogenesis of autoimmune arthritis

1994; Wiley; Volume: 24; Issue: 8 Linguagem: Inglês

10.1111/j.1365-2362.1994.tb01100.x

1365-2362

JJ Taylor, David A. Ross, John Goodacre,

Dermatological and COVID-19 studies

European Journal of Clinical InvestigationVolume 24, Issue 8 p. 511-521 Group A streptococcal antigens and superantigens in the pathogenesis of autoimmune arthritis J. E. TAYLOR, J. E. TAYLOR Rheumatology Laboratory, Catherine Cookson Building, The Medical School, Framlington Place, University of Newcastle upon Tyne, Newcastle upon Tyne NE2 4HH, UK.Search for more papers by this authorD. A. ROSS, D. A. ROSS Rheumatology Laboratory, Catherine Cookson Building, The Medical School, Framlington Place, University of Newcastle upon Tyne, Newcastle upon Tyne NE2 4HH, UK.Search for more papers by this authorJ. A. GOODACRE, J. A. GOODACRE Rheumatology Laboratory, Catherine Cookson Building, The Medical School, Framlington Place, University of Newcastle upon Tyne, Newcastle upon Tyne NE2 4HH, UK.Search for more papers by this author J. E. TAYLOR, J. E. TAYLOR Rheumatology Laboratory, Catherine Cookson Building, The Medical School, Framlington Place, University of Newcastle upon Tyne, Newcastle upon Tyne NE2 4HH, UK.Search for more papers by this authorD. A. ROSS, D. A. ROSS Rheumatology Laboratory, Catherine Cookson Building, The Medical School, Framlington Place, University of Newcastle upon Tyne, Newcastle upon Tyne NE2 4HH, UK.Search for more papers by this authorJ. A. GOODACRE, J. A. GOODACRE Rheumatology Laboratory, Catherine Cookson Building, The Medical School, Framlington Place, University of Newcastle upon Tyne, Newcastle upon Tyne NE2 4HH, UK.Search for more papers by this author First published: August 1994 https://doi.org/10.1111/j.1365-2362.1994.tb01100.xCitations: 11AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Bisno AL. Group A streptococcal infections and acute rheumatic fever. N Engl J Med 1991; 325; 783–93. 2 Stollerman GH. Rheumatogenic streptococci and autoimmunity. Clin Immunol Immunopathol 1991; 61: 131–42. 3 Gupta RC, Badhwar AK, Bisno AL, Berrios X. Detection of C reactive protein, streptolysin O, and anti-streptolysin O antibodies in immune complexes isolated from the sera of patients with acute rheumatic fever. J Immunol 1986; 137: 2173–9. 4 Bahr GM, Majeed HA, Yousof AM, Chedid L, Behbehani K. Detection of antibodies to muramyl dipeptide, the adjuvant moiety of streptococcal cell wall, in patients with rheumatic fever. J infect Dis 1986; 154: 1012–7. 5 Arnold MH, Tyndall A. Poststreptococcal reactive arthritis. Ann Rheum Dis 1989; 48: 686–8. 6 Livneh A, Sharma K, Sewell KL, Keiser HD. Multisystem disease in post-streptococcal arthritis. Ann Rheum Dis 1991; 50: 328–9. 7 Mageed RA, Vecovsky J, Maini RN. Rheumatoid factors and germline genes in rheumatoid arthritis: evidence of an intrinsic B lymphocyte defect? Br J Rheumatol 1994; 33: 105–7. 8 Panayi GS, Lanchbury JS, Kingsley GH. The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis. Arthritis Rheum 1992; 35: 729–35. 9 Ollier W, Thomson W. Population genetics of rheumatoid arthritis. Rheumatic Diseases Clinics of North America 1992; 18: 741–59. 10 Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. Arthritis Rheum 1987; 30: 1205–13. 11 Walport MJ, Ollier WER, Silman AJ. Immunogenetics of rheumatoid arthritis and the Arthritis and Rheumatism Council's national repository. Br J Rheumatol 1992; 31: 701–5. 12 Silman AJ, MacGregor AJ, Thomson W, Holligan S, Carthy D, Farhan A, Ollier WER. Twin concordance rates for rheumatoid arthritis: results from a nationwide study. Br J Rheumatol 1993; 32: 903–7. 13 Van Eden W, Thole JER, Van der Zee R, Noordzij A, Van Embden JDA, Hensen EJ, Cohen IR. Cloning of the mycobacterial epitope recognised by T lymphocytes in adjuvant arthritis. Nature 1998; 331: 171–3. 14 Gaston JSH, Life P, Bailey LC, Bacon PA. In vitro responses to a 65 kilodalton mycobacterial protein by synovial T cells from inflammatory arthritis patients. J Immunol 1989; 143: 2494–2500. 15 Pope RM, Pahlavani MA, Lacour E, Sambol S, Desai BV. Antigenic specificity of rheumatoid synovial fluid lymphocytes. Arthritis Rheum 1989; 32: 1371–80. 16 Fischer HP, Sharrock CEM, Colston MJ, Panayi GS. Limiting dilution analysis of proliferative T cell responses to mycobacterial 65 kDa heat shock protein fails to show significant frequency differences between synovial fluid and peripheral blood of patients with rheumatoid arthritis. Eur J Immunol 1991; 21: 2937–41. 17 Thompson SJ, Rook GAW, Brealey RJ, Van der Zee R, Elson CJ. Autoimmune reactions to heat shock proteins in pristaneinduced arthritis. Eur J Immunol 1990; 20: 2479–84. 18 Billingham MEJ, Carney S, Butler R, Colston MJ. A mycobacterial 65 kD heat shock protein induces antigen specific suppression of adjuvant arthritis but is not itself arthritogenic. J Exp Med 1990; 171: 339–44. 19 Van den Broek MF, Hogervorst EJM, Van Bruggen MCJ, Van Eden W, Van der Zee R, Van den Berg WB. Protection against streptococcal cell wall-induced arthritis by pre-treatment with the 65-kD mycobacterial heat shock protein. J Exp Med 1989; 170: 449–66. 20 Anderton SM, Van der Zee R, Goodacre JA. Inflammation activates self hsp60-specific T cells. Eur J Immunol 1993; 23: 33–8. 21 Ebringer A, Khalafapour S, Wilson C. Rheumatoid arthritis and Proteus: a possible aetiological association. Rheumatol Int 1989; 9: 223–8. 22 Deighton CM, Gray J, Bint AJ, Walker DJ. Anti-Proteus antibodies in rheumatoid arthritis same-sexed siblings. Br J Rheumatol 1992; 31: 241–5. 23 McDonagh J, Gray J, Sykes H, Walker DJ, Bint AJ, Deighton CM. Anti-Proteus antibodies and Proteus organisms in rheumatoid arthritis: a clinical study. Br J Rheumatol 1994; 33: 32–5. 24 Johnson PM, Phua KK, Perkins HR, Hart CA, Bucknall RC. Antibody to streptococcal cell wall peptidoglycan-polysaccharide polymers in seropositive and seronegative rheumatic disease. Clin Exp Immunol 1984; 55: 115–24. 25 Pope RM, Rutstein JE, Strauss DC, Chang D. Antibodies to the immunodominant portion of streptococcal mucopeptide (pentapeptide) in patients with rheumatic disorders. Arthritis Rheum 1979; 22: 648. 26 Schleifer K-H, Krause RM. The immunochemistry of peptidoglycan. I. The immunodominant site of the peptide subunit and the contribution of each of the amino acids to the binding properties of the peptides. J Biol Chem 1971; 246: 986–93. 27 Heymer B, Schleifer K-H, Read S, Zabriskie JB, Krause RM. Detection of antibodies to bacteral cell wall peptidoglycan in human sera. J Immunol 1976; 117: 23–6. 28 Cromartie WJ, Craddock JG, Schwab JH, Anderle S, Yang CH. Arthritis in rats after systemic injection of streptococcal cells or cell walls. J Exp Med 1977; 146: 1585–1602. 29 Wilder RL, Calandra GB, Garvin JA, Wright KD, Hansen CT. Strain and sex variation in the susceptibility to streptococcal cell wall-induced polyarthritis in the rat. Arthritis Rheum 1982; 25: 1064–72. 30 Koga T, Kakimoto K, Hirofuji T et al. Acute joint inflammation in mice after systemic injection of the cell wall, its pepti-doglycan and chemically defined peptidoglycan subunits from various bacteria. Infect Immunity 1985; 50: 27–34. 31 Dejoy SQ, Ferguson KM, Sapp TM, Zabriskie JB, Oronsky AL, Kerwar SS. Streptococcal cell wall arthritis. Passive transfer of disease with a T cell line and crossreactivity of streptococccal cell wall antigens with Mycobacterium tuberculosis. J Exp Med 1989; 170: 369–82. 32 Ridge SC, Zabriskie JB, Oronsky AL, Kerwar SS. Streptococcal cell wall arthritis: studies with nude (athymic) inbred Lewis rats. Cell Immunol 1985; 96: 231–4. 33 Yocum DE, Allen JB, Wahl SM, Calandra GB, Wilder R. Inhibition by cyclosporin A of streptococcal cell wall-induced arthritis hepatic granulomas in rats. Arthritis Rheum 1986; 29: 262–73. 34 Van den Broek MF, Van Bruggen MC, Koopman JP, Van den Berg WB. Gut flora induces and maintains resistance against streptococcal cell wall induced arthritis in F344 rats. Clin Exp Immunol 1992; 88: 313–7. 35 Stemberg EM, Hil JM, Chrousos GF, Kamilaris T, Listwak SJ, Gold PN, Wilder RL. Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis susceptible Lewis rats. Proc Natl Acad Sci USA 1989; 86: 2374–8. 36 Van den Broek MF, de Her E, Van Bruggen MC, de Roo G, Kleiverde K, Eulderink F, Van den Berg WB. Immunomodulation of streptococcal cell wall induced arthritis. Identification of inflammatory cells and regulatory T cell subsets by mercuric chloride and in vivo CD8 depletion. Eur J Immunol 1992; 22: 3091–5. 37 Esser RE, Stimpson SA, Cromartie WJ, Schwab JH. Reactivation of streptococcal cell wall-induced arthritis by homologous and heterologous cell wall polymers. Arthritis Rheum 1985; 28: 1402–1411. 38 Stimpson SA, Dalldorf FG, Otterness IG, Schwab JH. Exacerbation of arthritis by IL-1 in rat joints previously injured by peptidoglycan-polysaccharide. J Immunol 1988; 140: 2964–9. 39 Yoshino S, Cleland LG, Mayrhofer G, Brown RR, Schwab JH. Prevention of chronic erosive streptococcal cell wall-induced arthritis in rats by treatment with a monoclonal antibody against T cell antigen receptor αβ. J Immunol 1991; 146: 4187–9. 40 Allen JB, Bansal GP, Feldman GH, Hand AO, Wahl LM, Wahl SM. Suppression of bacterial cell wall-induced polyarthritis by recombinant gamma interferon. Cytokine 1991; 3: 98–106. 41 Haraoui B, Wilder RL, Allen JB, Sporn MB, Helfgott RK, Brinckerhoff CE. Dose-dependent suppression by the synthetic retinoid, 4-hydroxyphenyl retinamide, of streptococcal cell wall-induced arthritis in rats. Int J Immunopharmacol 1985; 7: 903–16. 42 Germain RN. MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activation. Cell 1994; 76: 287–99. 43 Chicz RM, Urban RG, Gorga JC, Vignali AA, Lane WS, Strominger JL. Specificity and promiscuity among naturally processed peptides bound to HLA DR alleles. J Exp Med 1993; 178: 27–47. 44 Paul WE, Seder RA. Lymphocyte responses and cytokines. Cell 1994; 76: 241–51. 45 Fischetti VA. Streptococcal M protein: molecular design and biological behaviour. Clin Microbiol Rev 1989; 2: 285–314. 46 Robinson JH, Kehoe M. Group A streptococcal M proteins: virulence factors and protective antigens. Immunol Today 1992; 13: 362–7. 47 McFadden J, Valdimarsson H, Fry L. Cross-reactivity between streptococcal M surface antigen and human skin. Br J Dermatol 1991; 125: 443–7. 48 Cavelti PA. Autoantibodies in rheumatic fever. Proc Soc Exp Biol Med 1945; 60: 379–81. 49 Kaplan MH, Suchy ML. Immunological relation of streptococcal and tissue antigens. II. Cross-reactions of antisera to mammalian heart tissue with a cell wall constituent of certain strains of group A streptococci. J Exp Med 1964; 119: 643–50. 50 Cunningham MW, McCormack JM, Fenderson PG, Ho MK, Beachey EH, Dale JB. Human and murine antibodies crossreactive with streptococcal M protein and myosin recognise the sequence GLN-LYS-SER-LYS-GLN in M protein. J Immunol 1989; 143: 2677–83. 51 Fenderson PG, Fischetti VA, Cunningham MW. Tropomyosin shares immunologic epitopes with group A streptococcal M proteins. J Immunol 1989; 142: 2475–81. 52 Baird RW, Bronze MS, Kraus W, Hill HR, Veasey LG, Dale JB. Epitopes of group A streptococcal M protein shared with antigens in articular cartilage and synovium. J Immunol 1991; 146: 3132–7. 53 Barnett LA, Cunningham MW. A new heart cross-reactive antigen in Streptococcus pyogenes is not M protein. J Infect Dis 1990; 162: 875–82. 54 Robinson JH, Atherton MC, Goodacre JA, Pinkney M, Weightman H, Kehoe MA. Mapping T cell epitopes in group A streptococcal type 5 M protein. Infect Immunity 1991; 59: 4324–31. 55 Pruksakorn S, Galbraith A, Houghten RA, Good MF. Conserved T and B cell epitopes on the M protein of group A streptococci. J Immunol 1992; 149: 2729–35. 56 Kotb M, Majumdar G, Tomai M, Beachey EH. Accessory cell independent stimulation of human T cells by streptococcal M protein. J Exp Med 1990; 145: 1332–6. 57 Tomai M, Kotb M, Majumdar G, Beachey EH. Superantigenicity of streptococcal M protein. J Exp Med 1990; 172: 359–62. 58 Tomai MA, Aelion JA, Dockter ME, Majumdar G, Spinella DG, Kotb M. T cell receptor V gene usage by human T cells stimulated with the superantigen streptococcal M protein. J Exp Med 1991; 174: 285–8. 59 Fleischer B, Schmidt KH, Gerlach D, Kohler W. Separation of T cell stimulating activity from streptococcal M protein. Infect Immunity 1992; 60: 1767–70. 60 Taylor JE, Robinson JH, Kehoe M, Goodacre JA. Identification of an epitope in the carboxy-terminal region of S. pyogenes type 5M protein which is recognised by human T cells. Br J Rheumatol 1994; 33: 18. 61 Raeder R, Boyle MP. Association between expression of immunoglobulin G-binding proteins by group A streptococci and virulence in a mouse skin infection model. Infect Immunity 1993; 61: 1378–84. 62 Abo T, Sugawara S, Seki S, Fujii M, Rikiishi H, Takeda K, Kumagai K. Induction of human TCRγδ+ and TCRγδ- CD2 + 3- double negative lymphocytes by bacterial stimulation. Int Immunol 1990; 2: 775–85. 63 Sato T, Fujii M, Satoh H, Itoh T, Rikiishi H, Kumagai K. Polyclonal activation of human lymphocytes and induction of cytotoxic lymphocytes by streptococcal preparations. Biotherapy 1992; 4: 53–63. 64 Itoh T, Satoh H, Isono N, Rikiishi H, Kumagai K. Mechanism of stimulation of T cells by Streptococcus pyogenes: Isolation of a major mitogenic factor, cytoplasmic membrane-associated protein. Infect Immunity 1992; 60: 3128–35. 65 Heymer B, Rietschel ET. Biological properties of peptidoglycans. In: D. Schlesinger ed. Microbiology—1977. Washington D.C. : American Society for Microbiology, 1977: 344–9. 66 Schwab JH. Phlogistic properties of peptidoglycan-polysac-charide polymers from cell walls of pathogenic and normal flora bacteria which colonise humans. Infect Immunity 1993; 61: 4535–9. 67 Schleifer K, Seidle PH. The immunochemistry of peptidoglycan. Antibodies against a synthetic immunogen cross-reacting with peptidoglycan. Eur J Biochem 1974; 43: 509–19. 68 Coligan JE, Kindt TJ, Krause RM. Structure of the streptococcal groups A, A-variant and C carbohydrates. Biochemistry 1978; 15: 755–60. 69 Suzuki J, Kobayashi S, Kagaya K, Fukazawa Y. Heterogeneity of haemolytic efficiency and isoelectric point of streptolysin O. Infect Immunity 1988; 56: 2474–8. 70 Kehoe MA, Miller L, Walker JA, Boulnois GJ. Nucleotide sequence of the streptolysin O (SLO) gene: structural homologies between SLO and other membrane, thiol-activated proteins. Infect Immunity 1987; 55: 3228–32. 71 Shany S, Bernheimer AW, Grushoff PS, Kim K-S. Evidence for membrane cholesterol as the common binding site for cereolysin, streptolysin O and saponin. Cell Molec Biochem 1974; 3: 179–86. 72 Ferrieri P. Immune response to streptococcal infections. In: NE Rose, H Friedman, JL Fahey, eds. Manual of Clinical Laboratory Immunology. Washington D.C. : American Society for Microbiology, 1986: 336–41. 73 Schlievert PM. Role of superantigens in human disease. J Infect Dis 1993; 167: 997–1002. 74 Braun MA, Gerlach D, Hartwig UF et al. Stimulation of human T cells by streptococcal “superantigen” erythrogenic toxins (scarlet fever toxins). J Immunol 1993; 150: 2457–66. 75 Abe J, Forrester J, Nakahara T, Lafferty JA, Kotzin B, Leung DYM. Selective stimulation of human T cells with streptococcal erythrogenic toxins A and B. J Immunol 1991; 146: 3747–50. 76 Tomai MA, Schlievert PM, Kotb M. Distinct T cell receptor Vβ usage by human T lymphocytes stimulated with the streptococcal pyrogenic exotoxins and pep M5 protein. Infect Immunity 1992; 60: 701–5. 77 Mollick JA, Miller GG, Musser JM, Cook RG, Grossman D, Rich RR. A novel superantigen isolated from pathogenic strains of Streptococcus pyogenes with aminoterminal homology to staphylococcal enterotoxins B and C. J Clin Invest 1993; 92: 710–19. 78 Acha-Orbea H. Bacterial and viral superantigens: roles in autoimmunity? Ann Rheum Dis 1993; 52: S6–S16. 79 Kotzin BL, Leung DYM, Kappler J, Marrack P. Superantigens and their potential role in human disease. Adv Immunol 1993; 54: 99–166. 80 Duby AD, Sinclair AK, Osborne-Lawrence SL, Zeldes W, Kan L, Fox DA. Clonal heterogeneity of synovial fluid T lymphocytes from patients with rheumatoid arthritis. Proc Natl Acad Sci USA 1989; 86: 6206–10. 81 Van Laar JM, Miltenburg AMM, Verdonk MJA et al. Lack of T cell oligoclonality in enzyme-digested synovial tissue and in synovial fluid in most patients with rheumatoid arthritis. Clin Exp Immunol 1991; 83: 352–8. 82 Paliard X, West SG, Laferty JA et al. Evidence for the effects of a superantigen in rheumatoid arthritis. Science 1991; 21: 461–6. 83 Howell MD, Diveley JP, Lundeen KA et al. Limited T cell receptor β chain heterogeneity among interleukin 2 receptorpositive synovial T cells suggests a role for superantigen in rheumatoid arthritis. Proc Natl Acad Sci USA 1991; 88: 10921–5. 84 Williams WV, Kieber-Emmons T, Fang Q et al. Conserved motifs in rheumatoid arthritis synovial tissue T cell receptor β chains. DNA and Cell Biology 1993; 12: 425–34. 85 Sottini A, Imberti L, Gorla R, Cattaneo R, Primi D. Restricted expression of T cell receptor Vβ but not Vα genes in rheumatoid arthritis. Eur J Immunol 1991; 21: 461–6. 86 Rijnders A, Van der Maaden H, Bertens A, Graus A, Boots A. TCR variable gene usage in recently inflamed tissue of rheumatoid arthritis patients. J Cell Biochem 1993; 17B: EZ216. 87 Dersimonian H, Sugita M, Glass DN et al. Clonal Vα12.1 + T cell expansions in the peripheral blood of rheumatoid arthritis patients. J Exp Med 1993; 177: 1623–31. 88 Cole BC, Griffiths, MM. Triggering and exacerbation of autoimmune arthritis by Mycoplasma arthritidis superantigen MAM. Arthritis Rheum 1993; 36: 994–1002. 89 Schwab JH, Brown RR, Anderle SK, Schlievert PM. Superantigen can reactivate bacterial cell wall-induced arthritis. J Immunol 1993; 150: 4151–9. 90 Brocke S, Gaur A, Piercy C et al. Induction of relapsing paralysis in experimental autoimmune encephalomyelitis by bacterial superantigen. Nature 1993; 365: 642–4. 91 Powrie F, Coffman RL. Cytokine regulation of T cell function: potential for therapeutic intervention. Immunology Today 1993; 14: 270–4. 92 Hsieh C-S, Macatonia SE, Tripp CS, Wolf SF, O'Garra A, Murphy KM. Development of Th1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 1993; 260: 547–9. 93 Gajewski TF, Pinnas M, Wong T, Fitch FW. Murine Th1 and Th2 clones proliferate optimally in response to distinct antigen presenting cell populations. J Immunol 1991; 146: 1750–8. 94 Janeway CA Jr, Bottomly K. Signals and signs for lymphocyte responses. Cell 1994; 76: 275–85. 95 Street NK, Schumacher JH, Fong AT et al. Heterogeneity of mouse helper T cells. Evidence from bulk cultures and limiting dilution cloning for precursors of Th1 and Th2 cells. J Immunol 1990; 144: 1629–39. 96 Schwartz RH. Immune response (Ir) genes of the murine major histocompatibility complex. Adv Immunol 1986; 38: 31–201. 97 Hill AVS, Elvin J, Willis AC et al. Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 1992; 360: 434–9. 98 Sasazuki T, Nishimura Y, Muto M, Ohta N. HLA-linked genes controlling immune response and disease susceptibility. Immunol Rev 1983; 70: 51–75. 99 Kamikawaji N, Fujisawa K, Yoshizumi H et al. HLA DQ-restricted CD4+ T cells specific to streptococcal antigen present in low but not in high responders. J Immunol 1991; 146: 2560–7. 100 Ayoub EM, Barret DJ, Maclaren NK, Krischer JP. Association of class II human histocompatibility leucocyte antigens with rheumatic fever. J Clin Invest 1986; 77: 2019–26. 101 Ertug MH. HLA DR antigens in rheumatic fever and rheumatic heart disease patients. Br J Rheumatol 1993; 32: 347–8. 102 Monplaisir N, Valette I, Bach J-F. HLA antigens in 88 cases of rheumatic fever observed in Martinque. Tissue Antigens 1986; 28: 209–13. 103 Khanna AK, Buskirk DR, Williams RC Jr et al. Presence of a non-HLA B cell antigen in rheumatic fever patients and their families as defined by a monoclonal antibody. J Clin Invest 1989; 83: 1710–6. Citing Literature Volume24, Issue8August 1994Pages 511-521 ReferencesRelatedInformation